[1]
2020. Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the “high clinical risk” category?. Acta Biomedica Atenei Parmensis. 91, 2 (May 2020), 50–56. DOI:https://doi.org/10.23750/abm.v91i2.9592.